These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 19335705)

  • 1. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health outcomes among patients receiving oseltamivir.
    Enger C; Nordstrom BL; Thakrar B; Sacks S; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):227-37. PubMed ID: 15255089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.
    Nordstrom BL; Oh K; Sacks ST; L'Italien GJ
    Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.
    Casscells SW; Granger E; Kress AM; Linton A; Madjid M; Cottrell L
    Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):108-15. PubMed ID: 20031822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review.
    Toovey S; Prinssen EP; Rayner CR; Thakrar BT; Dutkowski R; Koerner A; Chu T; Sirzen-Zelenskaya A; Britschgi M; Bansod S; Donner B
    Adv Ther; 2012 Oct; 29(10):826-48. PubMed ID: 23054689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
    L'Huillier AG; Ing Lorenzini K; Crisinel PA; Rebsamen MC; Fluss J; Korff CM; Barbe RP; Siegrist CA; Dayer P; Posfay-Barbe KM; Desmeules JA;
    Pharmacogenomics; 2011 Oct; 12(10):1493-501. PubMed ID: 21902503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New influenza A (H1N1): advised indication and prescription of antiviral drugs].
    van den Wijngaard CC; van Steenbergen JE; van der Sande MA; Koopmans MP
    Ned Tijdschr Geneeskd; 2009; 153():A1053. PubMed ID: 19857317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir and abnormal behaviors: true or not?
    Yorifuji T; Suzuki E; Tsuda T
    Epidemiology; 2009 Jul; 20(4):619-21. PubMed ID: 19367165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
    Toovey S; Rayner C; Prinssen E; Chu T; Donner B; Thakrar B; Dutkowski R; Hoffmann G; Breidenbach A; Lindemann L; Carey E; Boak L; Gieschke R; Sacks S; Solsky J; Small I; Reddy D
    Drug Saf; 2008; 31(12):1097-114. PubMed ID: 19026027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric concerns related to influenza treatment.
    Vantine M; Falahee ML; Vallerand AH
    Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of influenza infection managed with oseltamivir in lung transplant recipients.
    Ison MG; Sharma A; Shepard JA; Wain JC; Ginns LC
    J Heart Lung Transplant; 2008 Mar; 27(3):282-8. PubMed ID: 18342750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection.
    Tanabe T; Hara K; Nakajima M; Shimakawa S; Tamai H
    Brain Dev; 2010 Jun; 32(6):440-4. PubMed ID: 19200672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir: neuropsychiatric disorders.
    Prescrire Int; 2007 Oct; 16(91):200. PubMed ID: 17926837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.
    Greene SK; Li L; Shay DK; Fry AM; Lee GM; Jacobsen SJ; Baxter R; Irving SA; Jackson ML; Naleway AL; Nordin JD; Narwaney KJ; Lieu TA
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):335-44. PubMed ID: 23129321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 58(51):1436-40. PubMed ID: 20057350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.